- Home
- MLYS vs GNK Comparison
MLYS vs GNK Comparison
Compare MLYS & GNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- GNK
- Stock Information
- Founded
- MLYS 2019
- GNK 2004
- Country
- MLYS United States
- GNK United States
- Employees
- MLYS N/A
- GNK N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- GNK Marine Transportation
- Sector
- MLYS Health Care
- GNK Consumer Discretionary
- Exchange
- MLYS Nasdaq
- GNK Nasdaq
- Market Cap
- MLYS 634.6M
- GNK 596.0M
- IPO Year
- MLYS 2023
- GNK 2005
- Fundamental
- Price
- MLYS $10.29
- GNK $14.29
- Analyst Decision
- MLYS Strong Buy
- GNK Strong Buy
- Analyst Count
- MLYS 2
- GNK 5
- Target Price
- MLYS $30.00
- GNK $24.20
- AVG Volume (30 Days)
- MLYS 273.6K
- GNK 403.6K
- Earning Date
- MLYS 11-11-2024
- GNK 02-19-2025
- Dividend Yield
- MLYS N/A
- GNK 11.24%
- EPS Growth
- MLYS N/A
- GNK 527.82
- EPS
- MLYS N/A
- GNK 1.58
- Revenue
- MLYS N/A
- GNK $439,330,000.00
- Revenue This Year
- MLYS N/A
- GNK $7.38
- Revenue Next Year
- MLYS N/A
- GNK N/A
- P/E Ratio
- MLYS N/A
- GNK $8.82
- Revenue Growth
- MLYS N/A
- GNK 11.14
- 52 Week Low
- MLYS $8.58
- GNK $13.51
- 52 Week High
- MLYS $16.91
- GNK $23.43
- Technical
- Relative Strength Index (RSI)
- MLYS 43.56
- GNK 44.52
- Support Level
- MLYS $9.18
- GNK $13.93
- Resistance Level
- MLYS $9.97
- GNK $14.54
- Average True Range (ATR)
- MLYS 0.85
- GNK 0.42
- MACD
- MLYS -0.08
- GNK 0.07
- Stochastic Oscillator
- MLYS 38.05
- GNK 47.64
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, the ocean transportation of drybulk cargoes through the ownership and operation of drybulk carrier vessels. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters.